Disseminated Salmonella typhimurium infection secondary to infliximab treatment.
Fu
Angela
A
Bertouch
Jim V
JV
McNeil
H Patrick
HP
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology; D000069285:Infliximab; D008297:Male; D012480:Salmonella Infections / Q000209:etiology*; D012486:Salmonella typhimurium / Q000302:isolation & purification*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab